Factors Associated with Radiographic Progression in Patients with Rheumatoid Arthritis Who Were Treated with Methotrexate

REFERENCES

1. 1.↵
   1. Mottonen T,
   2. Paimela L,
   3. Leirisalo-Repo M,
   4. Kautiainen M,
   5. Ilonen J,
   6. Hannonen P

   . Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy. Ann Rheum Dis 1998;57:533–59.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. van der Heijde DM,
   2. van Riel PL,
   3. van Leuween MA,
   4. van’t Hof MA,
   5. van Rijswijk MH,
   6. van de Putte LB

   . Prognostic factors for radiological damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519–25.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. van Zeben D,
   2. Breedveld FC

   . Prognostic factors in rheumatoid arthritis. J Rheumatol 1996;23 Suppl 44:31–3.

   OpenUrl
4. 4.↵
   1. Graudal N,
   2. Tarp U,
   3. Jurik AG,
   4. Galloe AM,
   5. Garred P,
   6. Milman N,
   7. et al.

   Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression. J Rheumatol 2000;27:47–57.

   OpenUrlPubMed
5. 5.↵
   1. van Leeuwen MA,
   2. van der Heijde DM,
   3. van Rijswijk MH,
   4. Houtman PM,
   5. van Riel PL,
   6. van de Putte LB,
   7. et al.

   Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425–9.

   OpenUrlPubMed
6. 6.↵
   1. Welsing PM,
   2. van Gestel AM,
   3. Swinkels HL,
   4. Kiemeney LA,
   5. van Riel PL

   . The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009–17.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Klareskog L,
   2. van der Heijde D,
   3. de Jager JP,
   4. Gough A,
   5. Kalden J,
   6. Malaise M,
   7. et al.

   Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675–81.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. van der Heijde DM,
   2. van Leuween MA,
   3. van Riel PL,
   4. van de Putte LB

   . Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp’s method (van der Heijde modification). J Rheumatol 1995;22:1792–6.

   OpenUrlPubMed
9. 9.↵
   1. Steinberg D,
   2. Colla P

   . CART: tree structures non-parametric data analysis. San Diego, CA: Salford Systems; 1995.
10. 10.↵
    1. Breiman L,
    2. Friedman JH,
    3. Olshen RA,
    4. Stone CJ

    . Classification and regression trees. Pacific Grove, CA: Wadsworth; 1984.
11. 11.↵
    1. Bathon JM,
    2. Martin RW,
    3. Fleischmann RM,
    4. Tesser JR,
    5. Schiff MH,
    6. Keystone EC,
    7. et al.

    A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586–93.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Jansen LM,
    2. van der Horst-Bruinsma IE,
    3. van Schaardenburg D,
    4. Bezemer PD,
    5. Dijkmans BA

    . Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924–7.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Smolen JS,
    2. van der Heijde DM,
    3. St. Clair EW,
    4. Emery P,
    5. Bathon JM,
    6. Keystone E,
    7. et al.

    Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab. Arthritis Rheum 2006;54:702–10.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Kalden JR

    . Expanding role of biologic agents in rheumatoid arthritis. J Rheumatol 2002;29 Suppl 66:27–37.

    OpenUrl